Efficacy of External Oblique Intercostal Block in Laparoscopic Bariatric Surgery
Launched by AL MASHFA MEDICAL CENTER · Oct 21, 2022
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age of 18 and 65;
- • American Society of Anesthesia (ASA) class II or III
- • elective laparoscopic bariatric procedure through trocars positioned at or above the um-bilicus (T10 dermatome).
- Exclusion Criteria:
- • preoperative chronic use or contraindication to opioid or NSAID
- • allergy to bupivacaine
- • local skin infection at the injection site of EOI or OSTAP blocks
- • liver or renal insufficiency
- • psychiatric, or neurological disease
- • prior open abdominal surgery above T10 dermatome
- • patients converted to open surgery; and patients expected to be subjected to more tissue trauma.
About Al Mashfa Medical Center
Al Mashfa Medical Center is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. With a commitment to high ethical standards and patient safety, the center collaborates with experienced healthcare professionals and researchers to explore new treatment options and improve therapeutic outcomes. Al Mashfa Medical Center aims to contribute to the global medical community by conducting rigorous studies that enhance the understanding of various health conditions, ultimately fostering the development of effective medical solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Khobar, Eastern Provence, Saudi Arabia
Patients applied
Trial Officials
Mohamed I ElSayed
Principal Investigator
Al Mashfa Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials